310 related articles for article (PubMed ID: 3018660)
1. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
2. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis.
Cunningham AL; Nelson PA; Fathman CG; Merigan TC
J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxic cell activity linked to time of recurrence of herpes labialis.
Rola-Pleszczynski M; Lieu H
Clin Exp Immunol; 1984 Jan; 55(1):224-8. PubMed ID: 6319058
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells. Kinetics in normal donors and patients with recurrent herpes labialis.
Rola-Pleszczynski M
J Clin Lab Immunol; 1981 Jul; 6(1):39-43. PubMed ID: 7265173
[TBL] [Abstract][Full Text] [Related]
6. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
7. gamma Interferon production appears to predict time of recurrence of herpes labialis.
Cunningham AL; Merigan TC
J Immunol; 1983 May; 130(5):2397-400. PubMed ID: 6403619
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production.
Klieman RL; Green JA; Spruance SL
J Med Virol; 1985 Jul; 16(3):289-96. PubMed ID: 2993499
[TBL] [Abstract][Full Text] [Related]
9. Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections.
Green JA; Weiss PN; Yeh TJ; Spruance SL
J Med Virol; 1985 Jul; 16(3):297-305. PubMed ID: 2993500
[TBL] [Abstract][Full Text] [Related]
10. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis.
Cunningham AL; Merigan TC
J Immunol; 1984 Jan; 132(1):197-202. PubMed ID: 6418797
[TBL] [Abstract][Full Text] [Related]
11. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
12. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
13. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
[TBL] [Abstract][Full Text] [Related]
15. Sequential production of IFN-alpha and immune-specific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus.
Green JA; Yeh TJ; Overall JC
J Immunol; 1981 Sep; 127(3):1192-6. PubMed ID: 6167619
[TBL] [Abstract][Full Text] [Related]
16. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
18. Immunological responses of patients with recurrent herpes genitalis.
Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F
Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109
[TBL] [Abstract][Full Text] [Related]
19. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
20. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
